NCT05400291
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
- Locations
-
- Aarhus University Hospital Aarhus, Denmark
Clinical trial condition
Renal Cancer
Explore clinical trials studying Renal Cancer. Study availability and eligibility vary by location and protocol.
114 public trials
41 recruiting studies
Renal Cancer trial results
Completed
Off Clamp Randomization
NCT01732120
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +10 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT05823545
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +10 more
- Locations
-
- Ondokuz Mayıs University, Department of Urology Samsun, Turkey (Türkiye)
Completed
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
NCT02643303
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Cancer, +65 more
- Locations
-
- Research Facility Atlanta, Georgia, United States
- Research Facility Lebanon, New Hampshire, United States
- Research Facility Buffalo, New York, United States
- Research Facility New York, United States
NCT03568435
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +10 more
- Locations
-
- Local Institution - 0001 Tokyo, Japan
NCT00199888
- Conditions
- Adenocarcinoma, Cancer of Kidney, Carcinoma, +20 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00199875
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT02111850
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +31 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
NCT02947165
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +38 more
- Locations
-
- Sarah Cannon Research Institute SC Nashville, Tennessee, United States
- Huntsman Cancer Institute SC Salt Lake City, Utah, United States
- Novartis Investigative Site Salzburg, Austria
- Novartis Investigative Site Toronto, Ontario, Canada
NCT05168761
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +10 more
- Locations
-
Not specified